Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 13492883
[patent_doc_number] => 20180297984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => THERAPEUTIC INHIBITORY COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/016167
[patent_app_country] => US
[patent_app_date] => 2018-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66705
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16016167
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/016167 | Therapeutic inhibitory compounds | Jun 21, 2018 | Issued |
Array
(
[id] => 16839393
[patent_doc_number] => 20210147405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => BICYCLIC HETEROAROMATIC UREA OR CARBAMATE COMPOUNDS FOR USE IN THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/621616
[patent_app_country] => US
[patent_app_date] => 2018-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34619
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16621616
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/621616 | BICYCLIC HETEROAROMATIC UREA OR CARBAMATE COMPOUNDS FOR USE IN THERAPY | Jun 13, 2018 | Abandoned |
Array
(
[id] => 18399300
[patent_doc_number] => 11661426
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-30
[patent_title] => Imidazole-containing inhibitors of ALK2 kinase
[patent_app_type] => utility
[patent_app_number] => 16/622816
[patent_app_country] => US
[patent_app_date] => 2018-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 149991
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 243
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622816
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/622816 | Imidazole-containing inhibitors of ALK2 kinase | Jun 13, 2018 | Issued |
Array
(
[id] => 17104299
[patent_doc_number] => 11124494
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-21
[patent_title] => Aryl heterocyclic piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists
[patent_app_type] => utility
[patent_app_number] => 16/619965
[patent_app_country] => US
[patent_app_date] => 2018-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15296
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16619965
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/619965 | Aryl heterocyclic piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists | Jun 7, 2018 | Issued |
Array
(
[id] => 18995837
[patent_doc_number] => 11912664
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Determining small molecule-protein and protein-protein interactions
[patent_app_type] => utility
[patent_app_number] => 16/620372
[patent_app_country] => US
[patent_app_date] => 2018-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 63
[patent_no_of_words] => 31638
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16620372
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/620372 | Determining small molecule-protein and protein-protein interactions | Jun 5, 2018 | Issued |
Array
(
[id] => 16305272
[patent_doc_number] => 10774050
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-15
[patent_title] => Pyrimidines as sodium channel blockers
[patent_app_type] => utility
[patent_app_number] => 15/996053
[patent_app_country] => US
[patent_app_date] => 2018-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39155
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15996053
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/996053 | Pyrimidines as sodium channel blockers | May 31, 2018 | Issued |
Array
(
[id] => 16877923
[patent_doc_number] => 11028056
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => Method for producing 3-arylpropionamide compound and 3-arylpropionic acid ester compound
[patent_app_type] => utility
[patent_app_number] => 16/616596
[patent_app_country] => US
[patent_app_date] => 2018-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7096
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616596
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616596 | Method for producing 3-arylpropionamide compound and 3-arylpropionic acid ester compound | May 29, 2018 | Issued |
Array
(
[id] => 17323558
[patent_doc_number] => 11214552
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-04
[patent_title] => Preparation method for azoxystrobin and intermediate thereof
[patent_app_type] => utility
[patent_app_number] => 17/040894
[patent_app_country] => US
[patent_app_date] => 2018-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3247
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17040894
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/040894 | Preparation method for azoxystrobin and intermediate thereof | May 29, 2018 | Issued |
Array
(
[id] => 13563737
[patent_doc_number] => 20180333416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => THERAPEUTIC COMPOUNDS AND COMPOSITIONS, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/984747
[patent_app_country] => US
[patent_app_date] => 2018-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15984747
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/984747 | Therapeutic compounds and compositions, and methods of use thereof | May 20, 2018 | Issued |
Array
(
[id] => 14185215
[patent_doc_number] => 20190112312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => INHIBITORS OF BRUTON'S TYROSINE KINASE
[patent_app_type] => utility
[patent_app_number] => 15/983921
[patent_app_country] => US
[patent_app_date] => 2018-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42825
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15983921
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/983921 | INHIBITORS OF BRUTON'S TYROSINE KINASE | May 17, 2018 | Abandoned |
Array
(
[id] => 17874306
[patent_doc_number] => 11446298
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Pyrimidine derivatives
[patent_app_type] => utility
[patent_app_number] => 16/614605
[patent_app_country] => US
[patent_app_date] => 2018-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38460
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16614605
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/614605 | Pyrimidine derivatives | May 16, 2018 | Issued |
Array
(
[id] => 13420493
[patent_doc_number] => 20180261789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => ORGANIC LIGHT EMITTING DIODE DEVICE
[patent_app_type] => utility
[patent_app_number] => 15/973650
[patent_app_country] => US
[patent_app_date] => 2018-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4997
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15973650
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/973650 | Organic light emitting diode device | May 7, 2018 | Issued |
Array
(
[id] => 16476155
[patent_doc_number] => 10851082
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-01
[patent_title] => Substituted aromatic n-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (MNK1) and 2 (MNK2)
[patent_app_type] => utility
[patent_app_number] => 15/970457
[patent_app_country] => US
[patent_app_date] => 2018-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19827
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15970457
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/970457 | Substituted aromatic n-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (MNK1) and 2 (MNK2) | May 2, 2018 | Issued |
Array
(
[id] => 14018869
[patent_doc_number] => 20190071428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => NOVEL SALT FORMS OF (R)-5-((E)-2-PYRROLIDIN-3-YLVINYL)PYRIMIDINE
[patent_app_type] => utility
[patent_app_number] => 15/962982
[patent_app_country] => US
[patent_app_date] => 2018-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18025
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15962982
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/962982 | Salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine | Apr 24, 2018 | Issued |
Array
(
[id] => 13504583
[patent_doc_number] => 20180303834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => PYRROLOPYRIMIDINE DERIVATIVES AS NR2B NMDA RECEPTOR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 15/961553
[patent_app_country] => US
[patent_app_date] => 2018-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38307
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15961553
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/961553 | Pyrrolopyrimidine derivatives as NR2B NMDA receptor antagonists | Apr 23, 2018 | Issued |
Array
(
[id] => 16009091
[patent_doc_number] => 20200179388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => VASODILATORS FOR TREATMENT OF HEART FAILURE
[patent_app_type] => utility
[patent_app_number] => 16/606451
[patent_app_country] => US
[patent_app_date] => 2018-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606451
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606451 | Vasodilators for treatment of heart failure | Apr 22, 2018 | Issued |
Array
(
[id] => 17649635
[patent_doc_number] => 11352349
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Type II topoisomerase inhibitors and methods of making and using thereof
[patent_app_type] => utility
[patent_app_number] => 16/606044
[patent_app_country] => US
[patent_app_date] => 2018-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 26035
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 364
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606044
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606044 | Type II topoisomerase inhibitors and methods of making and using thereof | Apr 16, 2018 | Issued |
Array
(
[id] => 13621917
[patent_doc_number] => 20180362510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => CHIRAL SYNTHESIS METHOD FOR PRODUCING CIS-IMIDAZOLINE COMPOUNDS FOR PHARMACEUTICAL USE
[patent_app_type] => utility
[patent_app_number] => 15/955474
[patent_app_country] => US
[patent_app_date] => 2018-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8501
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15955474
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/955474 | Chiral synthesis method for producing cis-imidazoline compounds for pharmaceutical use | Apr 16, 2018 | Issued |
Array
(
[id] => 15227461
[patent_doc_number] => 10501440
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-10
[patent_title] => Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/953523
[patent_app_country] => US
[patent_app_date] => 2018-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18691
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15953523
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/953523 | Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors | Apr 15, 2018 | Issued |
Array
(
[id] => 17649647
[patent_doc_number] => 11352361
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Compounds useful as RET inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/604332
[patent_app_country] => US
[patent_app_date] => 2018-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22969
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604332
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604332 | Compounds useful as RET inhibitors | Apr 12, 2018 | Issued |